Skip to main content
SpringerLink
Log in

Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis

  • Scientific Letter
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7(7):416–26.

    Article  CAS  Google Scholar 

  2. Ravelli A, Minoia F, Davì S, et al; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism/American College of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis. 2016;75:481–9.

    Article  CAS  Google Scholar 

  3. Kimura Y, Weiss JE, Haroldson KL, et al; Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013;65:745–52.

  4. Ruperto N, Brunner HI, Quartier P, et al; PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2396–406.

Download references

Author information

Authors and Affiliations

  1. Universidade de Fortaleza, Fortaleza, Ceará, Brazil

    Luciana Brandão Paim

  2. Pediatric Immunology/Rheumatology Unit, Pediatric Department of University of Florida, Gainesville, FL, USA

    Luciana Brandão Paim

  3. Albert Sabin Children’s Hospital, Fortaleza, Ceará, Brazil

    Maria Lidiane Lavour Landim, Sara Lourinho Firmino & Celia Maria Barbosa Elias Monteiro

  4. Escola Bahiana de Medicina, Salvador, Bahia, Brazil

    Luisa Rodrigues Cordeiro

  5. Rheumatology Division, Hospital Universitário Prof. Edgard Santos, School of Medicine Salvador, Federal University of Bahia, Salvador, Bahia, Brazil

    Fernando Glazner de Araujo

  6. Institute for Health Sciences from Federal University of Bahia, Rua das Violetas, 42, ap. 502, Pituba, Salvador, Bahia, Brazil

    Jozélio Freire de Carvalho

Authors
  1. Luciana Brandão Paim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Lidiane Lavour Landim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sara Lourinho Firmino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Celia Maria Barbosa Elias Monteiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luisa Rodrigues Cordeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando Glazner de Araujo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jozélio Freire de Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jozélio Freire de Carvalho.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paim, L.B., Landim, M.L.L., Firmino, S.L. et al. Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis. Indian J Pediatr 88, 608–609 (2021). https://doi.org/10.1007/s12098-021-03734-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-021-03734-4

Search

Navigation